TEVA – teva pharmaceutical industries limited american depositary shares (US:NASDAQ)
Stock Stats
News
Teva Upgrades Its 4PL Model, Enhancing Medicine Accessibility for Patients with Kerry Pharma
Lumicera Secures Purchase Agreement for Stelara® Biosimilar, Delivering Major Cost Savings [Yahoo! Finance]
Teva Pharmaceutical Industries Limited (NYSE: TEVA) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
Teva Pharmaceutical Industries Limited (NYSE: TEVA) had its price target lowered by analysts at Bank of America Co. from $23.00 to $20.00. They now have a "buy" rating on the stock.
United States Lidocaine Patches Market Report 2024 with Long-term Outlook, Competitive Landscape of Amneal, Endo, Hisamitsu, Medline, Scilex, Sparsha, Teikoku, Teva, Viatris, and YARAL [Yahoo! Finance]
Form 4 TEVA PHARMACEUTICAL INDU For: Mar 05 Filed by: Weiss Amir
Form 4 TEVA PHARMACEUTICAL INDU For: Mar 05 Filed by: Fox Christine
Form 4 TEVA PHARMACEUTICAL INDU For: Mar 05 Filed by: McAvoy David R.
Form 4 TEVA PHARMACEUTICAL INDU For: Mar 05 Filed by: Kalif Eliyahu Sharon
Form 4 TEVA PHARMACEUTICAL INDU For: Mar 05 Filed by: Hughes Eric A
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.